683 related articles for article (PubMed ID: 27768527)
1. Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013-2014.
Yao X; Bian LL; Lu WW; Li JX; Mao QY; Wang YP; Gao F; Wu X; Ye Q; Li XL; Zhu FC; Liang Z
Hum Vaccin Immunother; 2017 Apr; 13(4):823-830. PubMed ID: 27768527
[TBL] [Abstract][Full Text] [Related]
2. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden.
Ji H; Fan H; Lu PX; Zhang XF; Ai J; Shi C; Huo X; Bao CJ; Shan J; Jin Y
BMC Infect Dis; 2019 Jan; 19(1):79. PubMed ID: 30669973
[TBL] [Abstract][Full Text] [Related]
3. Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012-2013.
Yao X; Bian LL; Lu WW; Li JX; Mao QY; Wang YP; Gao F; Wu X; Ye Q; Xu M; Li XL; Zhu FC; Liang ZL
J Med Virol; 2015 Dec; 87(12):2009-17. PubMed ID: 26010334
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Nonpolio Enteroviruses in Children With Herpangina and Hand, Foot and Mouth Disease in Taiwan.
Yang TO; Arthur Huang KY; Chen MH; Chen PC; Huang WT
Pediatr Infect Dis J; 2019 Sep; 38(9):887-893. PubMed ID: 31033911
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of 555 outpatients with hand, foot and mouth diseases caused by different enteroviruses].
Cui P; Li Y; Zhou CC; Zhou YH; Song CL; Qiu Q; Wang F; Guo C; Han SJ; Liang L; Yuan Y; Zeng MY; Yue J; Long L; Qin XH; Li Z; Chen XL; Zou YP; Cheng YB; Yu HJ
Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):445-451. PubMed ID: 31216802
[No Abstract] [Full Text] [Related]
6. Ongoing change of severe hand, foot, and mouth disease pathogens in Yunnan, China, 2012 to 2016.
Du Z; Zhao Y; Luo Y; Du L; Gan Q; Zhang H; Li J; Yang Z; Ma S
J Med Virol; 2019 May; 91(5):881-885. PubMed ID: 30613995
[TBL] [Abstract][Full Text] [Related]
7. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.
Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H
PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540
[TBL] [Abstract][Full Text] [Related]
8. The spatial-temporal distribution and etiological characteristics of hand-foot-and-mouth disease before and after EV‑A71 vaccination in Kunming, China, 2017-2020.
Wang M; Chen T; Peng J; Luo Y; Du L; Lu Z; He J; Liu C; Gan Q; Ma W; Cun Z; Zheng Q; Chen W; Chen Y; Han M; Liu G; Li J
Sci Rep; 2022 Oct; 12(1):17028. PubMed ID: 36220850
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine.
Yang B; Liu F; Liao Q; Wu P; Chang Z; Huang J; Long L; Luo L; Li Y; Leung GM; Cowling BJ; Yu H
Euro Surveill; 2017 Dec; 22(50):. PubMed ID: 29258646
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of 45,616 suspect cases of Hand, Foot and Mouth Disease in Chongqing, China, 2011-2015.
Tao J; He XY; Shi Y; Zhu G; Liu S; Zhang Z; Tang S; Zhang R; Peng B; Liu Z; Tan J; Chen Q; Wang X; Bao L; Zou L; Zhang P
Sci Rep; 2017 Apr; 7():45630. PubMed ID: 28422128
[TBL] [Abstract][Full Text] [Related]
11. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.
Jiang H; Zhang Z; Rao Q; Wang X; Wang M; Du T; Tang J; Long S; Zhang J; Luo J; Pan Y; Chen J; Ma J; Liu X; Fan M; Zhang T; Sun Q
Emerg Microbes Infect; 2021 Dec; 10(1):619-628. PubMed ID: 33682641
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological and genetic analysis concerning the non-enterovirus 71 and non-coxsackievirus A16 causative agents related to hand, foot and mouth disease in Anyang city, Henan Province, China, from 2011 to 2015.
Li Y; Bao H; Zhang X; Zhai M; Bao X; Wang D; Zhang S
J Med Virol; 2017 Oct; 89(10):1749-1758. PubMed ID: 28480969
[TBL] [Abstract][Full Text] [Related]
13. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
Mao Q; Wang Y; Bian L; Xu M; Liang Z
Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal study on enterovirus A71 and coxsackievirus A16 genotype/subgenotype replacements in hand, foot and mouth disease patients in Thailand, 2000-2017.
Noisumdaeng P; Korkusol A; Prasertsopon J; Sangsiriwut K; Chokephaibulkit K; Mungaomklang A; Thitithanyanont A; Buathong R; Guntapong R; Puthavathana P
Int J Infect Dis; 2019 Mar; 80():84-91. PubMed ID: 30639624
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of Recurrent Hand, Foot and Mouth Disease, China, 2008-2015.
Huang J; Liao Q; Ooi MH; Cowling BJ; Chang Z; Wu P; Liu F; Li Y; Luo L; Yu S; Yu H; Wei S
Emerg Infect Dis; 2018 Mar; 24(3):432-42. PubMed ID: 29460747
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology and clinical characteristics of enteroviruses associated HFMD in Chengdu, China, 2013-2022.
Yang Q; Liu F; Chang L; Lai S; Teng J; Duan J; Jian H; Liu T; Che G
Virol J; 2023 Sep; 20(1):202. PubMed ID: 37661256
[TBL] [Abstract][Full Text] [Related]
17. Clinical, etiological and epidemiological investigations of hand, foot and mouth disease in southern Vietnam during 2015 - 2018.
Nhan LNT; Khanh TH; Hong NTT; Van HMT; Nhu LNT; Ny NTH; Nguyet LA; Thanh TT; Anh NT; Hang VTT; Qui PT; Viet HL; Tung TH; Ha DQ; Tuan HM; Thwaites G; Chau NVV; Thwaites L; Hung NT; van Doorn HR; Tan LV
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008544. PubMed ID: 32804980
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of enterovirus from children with herpangina or hand, foot, and mouth disease in Hangzhou, 2016.
Li W; Li C; Liu L; Liu X; Shang S; Mao H; Zhang Y
Arch Virol; 2019 Oct; 164(10):2565-2571. PubMed ID: 31321585
[TBL] [Abstract][Full Text] [Related]
19. Development of single-step multiplex real-time RT-PCR assays for rapid diagnosis of enterovirus 71, coxsackievirus A6, and A16 in patients with hand, foot, and mouth disease.
Puenpa J; Suwannakarn K; Chansaenroj J; Vongpunsawad S; Poovorawan Y
J Virol Methods; 2017 Oct; 248():92-99. PubMed ID: 28662914
[TBL] [Abstract][Full Text] [Related]
20. Coxsackievirus A6 was the most common enterovirus serotype causing hand, foot, and mouth disease in Shiyan City, central China.
Li JF; Zhang CJ; Li YW; Li C; Zhang SC; Wang SS; Jiang Y; Luo XB; Liao XJ; Wu SX; Lin L
World J Clin Cases; 2022 Nov; 10(31):11358-11370. PubMed ID: 36387823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
